Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02989818 · ClinicalTrials.gov registry record

Multi-center Evaluation of the Clinical Utility of ESD in the Western Population

A clinical trial of Endoscopic Submucosal Dissection, sponsored by University of Florida.

Recruiting
Registry status
300
Enrollment target
3
Study locations

NCT02989818 is a study of Endoscopic Submucosal Dissection that is actively recruiting participants, run by University of Florida. The registered enrollment target is 300 participants. The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02989818, a study of Endoscopic Submucosal Dissection, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
300 participants
Enrollment target
3
Study locations

Study Summary

The aim of this multi-center study is to prospectively document the clinical utility of ESD.

Interventions

  • OTHER Endoscopic Submucosal Dissection

Study Locations (3)

Florida

  • University of Florida - Gainesville

Massachusetts

  • Massachusetts General Hospital - Boston

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2016-03
Est. Completion 2026-01

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT02989818

The ClinicalTrials.gov registry entry for NCT02989818 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Endoscopic Submucosal Dissection appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic Submucosal Dissection is the first listed.

NCT02989818 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Massachusetts, Texas.

Frequently Asked Questions

What is clinical trial NCT02989818 about?

NCT02989818 is a clinical study titled "Multi-center Evaluation of the Clinical Utility of ESD in the Western Population". The aim of this multi-center study is to prospectively document the clinical utility of ESD.

What is the current status of trial NCT02989818?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2016-03. Estimated completion is 2026-01.

What conditions does trial NCT02989818 study?

This clinical trial studies the following conditions: Endoscopic Submucosal Dissection.

What interventions are being tested in trial NCT02989818?

The interventions under investigation include: Endoscopic Submucosal Dissection (OTHER).

Who is sponsoring clinical trial NCT02989818?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02989818 being conducted?

This trial has 3 study locations across Florida, Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endoscopic Submucosal Dissection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.